SB 308 Requires health benefit plans to establish equal out-of-pocket requirements for oral anticancer medications and intravenously administered chemotherapy medications
Sponsor: Schaaf
LR Number: 1594S.01I Fiscal Note available
Committee: Small Business, Insurance and Industry
Last Action: 5/17/2013 - S Informal Calendar S Bills for Perfection--SB 308-Schaaf Journal Page:
Title: Calendar Position:
Effective Date: August 28, 2013

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2013 Senate Bills

Current Bill Summary

SB 308 - Under this act, any health benefit plan that provides coverage and benefits for cancer chemotherapy treatment shall not require a higher copayment, deductible, or coinsurance amount for a prescribed, orally administered anticancer medication that is used to kill or slow the growth of cancerous cells than what the plan requires for an intravenously administered or injected cancer medication that is provided, regardless of formulation or benefit category determination by the health carrier administering the health benefit plan.

This act is similar to SB 577 (2012) and SB 262 (2011).